The Administered Price

Your income statement shows what you collected. It does not show what collections cost you, what you were prevented from collecting, or what you would have collected if the price had been set by a market instead of by a contract.

Fee schedules are administered prices. They are not the output of supply and demand finding equilibrium. They are quantities imposed by buyers with enough market concentration to make the imposition stick. The physician who wants to dispute a rate has one tool: exit the network. That tool costs more than the dispute is worth in almost every case, which is precisely why the rate stays where it is.

What that means structurally is that your reimbursement rate and your service quality have no reliable relationship. The rate does not rise when you see more patients, invest in better equipment, or reduce your wait times. It rises when the contract is renegotiated, if it rises at all.

The dashed line represents the market-clearing rate under competition. The administered rate falls as concentration rises. The shaded region is the annual gap between the two.A price that cannot respond to quality or productivity is not functioning as a price. It is a ceiling dressed up as a market outcome.

What High Volume Actually Buys

Standard economic logic says that a buyer who needs more of something scarce must pay more to secure it. Demand pressure on constrained supply pushes price up. That logic holds in competitive markets.

It does not hold when the buyer is large enough to credibly threaten exit. A health insurer that routes thirty percent of your patient volume does not need to bid for your participation. It needs only to make your departure more costly than your compliance. At that threshold, the relationship between volume and price inverts: higher patient flow from a single payer produces lower rates, not higher ones, because the dependency itself becomes the negotiating instrument.

The practical result is that your highest-volume insurer and your lowest-paying insurer are frequently the same entity. Most practice owners who have never mapped reimbursement rate against patient volume by payer find the correlation runs in exactly the wrong direction.

Revenue That Was Possible but Never Pursued

Practice schedules are almost never constructed from first principles. They form through accretion. A referral pattern develops, certain appointment types become standard, and the resulting time allocation gets treated as a given rather than a decision.

Every allocation decision has a shadow cost: what that same hour would have produced under a different choice. When the mix of procedures in a typical week is compared against the reimbursement rates those procedures carry, across insurers and across service types, the gap between actual and optimal allocation becomes visible. That gap is not lost revenue. It was never pursued. The schedule was not built to pursue it.

The distinction matters because lost revenue implies something went wrong. Foregone revenue means the question was never asked. Asking it for the first time produces a number most practice owners do not expect.

Overhead That Belongs to Someone Else

Every prior authorization that gets filed, denied, appealed, and eventually paid represents labor your practice absorbed to satisfy a process your insurer designed. The same is true for claim scrubbing, documentation audits, referral coordination, and the administrative tracking that surrounds each one.

These are not inefficiencies in your operation. They are workflow requirements your payers built into the relationship deliberately, because the cost of compliance falls on your staff, not theirs. The insurer that requires three-step prior authorization for a routine procedure did not miscalculate. They correctly identified who would pay for the friction, and it was not them.

That cost has never appeared as a line item. It is distributed across salary, time, and overhead in a way that makes it invisible until someone goes looking for it. When practices isolate it for the first time, they typically find it is larger than any named expense in the budget.

The Composite Number

Taken individually, each of these four figures is significant. The administered rate gap is a per-procedure number that multiplies across your annual visit volume. The volume-rate inversion is a ratio that can be calculated from your existing payer data. The foregone revenue from schedule misallocation is an annual figure that requires only your current reimbursement schedule and your appointment mix to compute. The imposed overhead cost requires isolating payer-compliance labor and expressing it as a dollar total.

Taken together, they produce a composite figure that describes the distance between what your practice currently earns and what the same practice, with the same physicians and the same patients, would earn inside a different structure.

That distance is not a symptom of poor management. It is the predictable output of a market structure that was designed to produce exactly this result. The question it raises is not why it happened. It is whether the structure is permanent.

It is not. But changing it requires knowing the number first.

The economics makes the what visible. My help makes the how possible.